AKRO
Akero Therapeutics Inc.
$46.41
+$1.19(+2.63%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$3.62B
Volume
864.72K
52W Range
$21.34 - $58.40
Target Price
$76.33
Key Metrics Overview
| Market Cap | $3.62B | P/E Ratio | N/A |
| 52W High | $58.40 | 52W Low | $21.34 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 67.6% |
| Overall Score | 40 | Value Score | -- |
| Quality Score | -- | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-3.74 | EPS Next Est | $-4.12 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKRO | $46.41 | +2.6% | 864.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |